Encompass Health Corporation (EHC) Tops Q1 EPS by 10c; offers guidance

Encompass Health Corporation (NYSE: EHC) reported Q1 EPS of $1.60, $0.10 better than the analyst estimate of $1.50. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.57 billion.

GUIDANCE:

Encompass Health Corporation sees FY2026 EPS of $5.89-$6.11, versus the consensus of $5.92. Encompass Health Corporation sees FY2026 revenue of $6.375-6.47 billion, versus the consensus of $6.42 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Full Circle Lithium closes $5.14M private placement
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c